intrauterine contraceptive or device (IUD)
Jump to navigation
Jump to search
Indications
- long-term contraception for women
- smokers & other women who cannot use oral contraceptives
Procedure
Complications
- pelvic inflammatory disease
- safe for adolescents[3]
- not associated with increased risk of venous thromboembolism[2]
- levonorgestrel-releasing IUDs associated with 40% increased risk of breast cancer[6]
Notes
More general terms
More specific terms
- intrauterine copper contraceptive (Paragard)
- levonorgestrel-releasing intrauterine system (Mirena, LNG-IUS, LILETTA, Skyla)
References
- ↑ Kaiser Permanente Northern California Regional Drug Formulary, 1998
- ↑ 2.0 2.1 Mantha S et al Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ 2012;345:e4944 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22872710 <Internet> http://www.bmj.com/content/345/bmj.e4944
- ↑ 3.0 3.1 Committee on Adolescent Health Care Committee Opinion No. 539: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices Obstetrics & Gynecology: October 2012, 120(4):983-988 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22996129 <Internet> http://journals.lww.com/greenjournal/Citation/2012/10000/Committee_Opinion_No__539___Adolescents_and.45.aspx
- ↑ 4.0 4.1 Medical Knowledge Self Assessment Program (MKSAP) 16 American College of Physicians, Philadelphia 2012
- ↑ 5.0 5.1 5.2 Foster DG et al. Interest in and experience with IUD self-removal. Contraception 2014 Jul; 90:54 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24613370 <Internet> http://www.contraceptionjournal.org/article/S0010-7824(14)00035-3/abstract
- ↑ 6.0 6.1 Morch LS, Meaidi A, Corn G et al Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024 Oct 16. PMID: https://www.ncbi.nlm.nih.gov/pubmed/39412770